A retrospective study comparing the response to treatment with TNFi in monotherapy and combined with csDMARDs in patients with psoriatic arthritis
Latest Information Update: 19 Jun 2021
At a glance
- Drugs Adalimumab (Primary) ; Certolizumab pegol (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Methotrexate (Primary) ; Corticosteroid
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 19 Jun 2021 New trial record
- 05 Jun 2021 Results presented at the 22nd Annual Congress of the European League Against Rheumatism